These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
637 related articles for article (PubMed ID: 27388491)
21. A Novel Long-circulating DOX Liposome: Formulation and Pharmacokinetics Studies. Xiao P; Zhao J; Huang Y; Jin R; Tang Z; Wang P; Song X; Zhu H; Yang Z; Yu N Pharm Nanotechnol; 2020; 8(5):391-398. PubMed ID: 32787769 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice. Al-Abd AM; Hong KY; Song SC; Kuh HJ J Control Release; 2010 Feb; 142(1):101-7. PubMed ID: 19819274 [TBL] [Abstract][Full Text] [Related]
23. An injectable hydrogel with pH-sensitive and self-healing properties based on 4armPEGDA and N-carboxyethyl chitosan for local treatment of hepatocellular carcinoma. Zhan J; Wu Y; Wang H; Liu J; Ma Q; Xiao K; Li Z; Li J; Luo F; Tan H Int J Biol Macromol; 2020 Nov; 163():1208-1222. PubMed ID: 32645496 [TBL] [Abstract][Full Text] [Related]
24. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy. Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602 [TBL] [Abstract][Full Text] [Related]
25. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Zhang J; Chen XG; Li YY; Liu CS Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086 [TBL] [Abstract][Full Text] [Related]
26. Functionalized graphene oxide-based thermosensitive hydrogel for magnetic hyperthermia therapy on tumors. Zhu X; Zhang H; Huang H; Zhang Y; Hou L; Zhang Z Nanotechnology; 2015 Sep; 26(36):365103. PubMed ID: 26291977 [TBL] [Abstract][Full Text] [Related]
27. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU). Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213 [TBL] [Abstract][Full Text] [Related]
28. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors. Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227 [TBL] [Abstract][Full Text] [Related]
29. Shear-responsive injectable supramolecular hydrogel releasing doxorubicin loaded micelles with pH-sensitivity for local tumor chemotherapy. Liu Z; Xu G; Wang C; Li C; Yao P Int J Pharm; 2017 Sep; 530(1-2):53-62. PubMed ID: 28739501 [TBL] [Abstract][Full Text] [Related]
30. An injectable, thermosensitive and multicompartment hydrogel for simultaneous encapsulation and independent release of a drug cocktail as an effective combination therapy platform. Wang W; Song H; Zhang J; Li P; Li C; Wang C; Kong D; Zhao Q J Control Release; 2015 Apr; 203():57-66. PubMed ID: 25683618 [TBL] [Abstract][Full Text] [Related]
31. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model. Zahmatkeshan M; Gheybi F; Rezayat SM; Jaafari MR Eur J Pharm Sci; 2016 Apr; 86():125-35. PubMed ID: 26972276 [TBL] [Abstract][Full Text] [Related]
32. Co-delivery of doxorubicin and (131)I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy. Huang P; Zhang Y; Wang W; Zhou J; Sun Y; Liu J; Kong D; Liu J; Dong A J Control Release; 2015 Dec; 220(Pt A):456-464. PubMed ID: 26562684 [TBL] [Abstract][Full Text] [Related]
33. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release. Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095 [TBL] [Abstract][Full Text] [Related]
34. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy. Qu J; Zhao X; Ma PX; Guo B Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902 [TBL] [Abstract][Full Text] [Related]
35. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance. Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761 [TBL] [Abstract][Full Text] [Related]
36. Defining cisplatin incorporation properties in thermosensitive injectable biodegradable hydrogel for sustained delivery and enhanced cytotoxicity. Abdel-Bar HM; Abdel-Reheem AY; Osman R; Awad GA; Mortada N Int J Pharm; 2014 Dec; 477(1-2):623-30. PubMed ID: 25445973 [TBL] [Abstract][Full Text] [Related]
37. In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan-doxorubicin conjugates. Cho YI; Park S; Jeong SY; Yoo HS Eur J Pharm Biopharm; 2009 Sep; 73(1):59-65. PubMed ID: 19409990 [TBL] [Abstract][Full Text] [Related]
38. Exhausting tumor associated macrophages with sialic acid-polyethyleneimine-cholesterol modified liposomal doxorubicin for enhancing sarcoma chemotherapy. Zheng H; Li J; Wang M; Luo X; Qiu Q; Hu L; Li C; Song Y; Deng Y Int J Pharm; 2019 Mar; 558():187-200. PubMed ID: 30654062 [TBL] [Abstract][Full Text] [Related]
40. Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer. Liang X; Gao J; Jiang L; Luo J; Jing L; Li X; Jin Y; Dai Z ACS Nano; 2015 Feb; 9(2):1280-93. PubMed ID: 25599568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]